Free Trial
NYSE:HRC

Hill-Rom (HRC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Price Target
N/A

Hill-Rom MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
11.49%
From $6.44 to $7.18 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.19 out of 5 stars

Medical Sector

597th out of 936 stocks

Surgical & Medical Instruments Industry

73rd out of 101 stocks

HRC stock logo

About Hill-Rom Stock (NYSE:HRC)

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

HRC Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Here Are The Best 37 Rom-Coms Ever Made
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/05/2021
Today
7/27/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
CUSIP
43147510
Employees
10,000
Year Founded
1929

Profitability

Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Book Value
$28.56 per share

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable
Beta
0.55

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • John P. Groetelaars
    President, Chief Executive Officer & Director
  • Tim Lawrence
    Senior Vice President-Operations
  • Barbara W. Bodem
    Chief Financial Officer & Senior Vice President
  • Brian L. Lawrence
    Chief Technology Officer & SVP-Innovation
  • Ilana Shulman
    Chief Compliance Officer

HRC Stock Analysis - Frequently Asked Questions

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.20. The business's quarterly revenue was up 13.1% on a year-over-year basis.

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom Chief Executive Officer John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among the company's employees.

Does Hill-Rom have any subsidiaries?

The following companies are subsidiaries of Hill-Rom: Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and more.

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), Block (SQ), PayPal (PYPL), Salesforce (CRM) and CVS Health (CVS).

This page (NYSE:HRC) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners